Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections

Indian Journal of Medical Microbiology

Volumn 30, Issue 1, 2012, Pages 76-80

  Wasfi, R ^a   Abd El Rahman, O A ^b   Mansour, L E ^d   Hanora, A S ^c   Hashem, A M ^d   Ashour, M S ^b  

^a October University for Modern Sciences and Arts   (Egypt)

^b Al Azhar University   (Egypt)

^c Suez Canal University   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Antimicrobial agents; biofilm; Proteus mirabilis; wound and urinary tract infections

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; NITROFURANTOIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; NONHUMAN; PROTEUS MIRABILIS;

EID: 84857815530     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.93044     Document Type: Article

References (14)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-22.
2. Olson ME, Ceri H, Morck DW, Buret AG, Read RR. Biofilm bacteria: Formation and comparative susceptibility to antibiotics. Can J Vet Res 2002;66:86-92.
3. Mahon CR, Manuselis CR. Textbook of Diagnostic Microbiology. 2nd ed. Philadelphia: Saunders Elsevier; 2007.
4. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R. Genetic approaches to study of biofilms. Methods Enzymol 1999;310:91-109.
5. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved Standard M7-A5. Wayne, PA, 2000
6. Yassien M, Khardori N. Biofilms formation by Staphylococcus epidermidis. modulation by fluoroquinolones. Egypt J Biomed Sci 2004;16:1-20.
7. Moskowitz SM, Foster JM, Emerson J, Burns L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J Clin Microbiol 2004;42:1915-22.
8. Ruzicka F, Hola V, Votava M, Tejkalova R, Horvath R, Heroldová M, et al. Biofilm detection and the clinical significance of Staphylococcus epidermidis isolates. Folia Microbiol 2004;49:596-600.
9. Smith K, Perez A, Ramage G, Lappin D, Gemmell CG, Lang S. Biofilm formation by Scottish clinical isolates of Staphylococcus aureus. J Med Microbiol 2008;57:1018-23.
10. Duran N, Dogramaci Y, Ozer B, Demir C, Kalaci A. Detection of adhesin genes and slime production among Staphylococci in orthopaedic surgical wounds. Afr J Microbiol Res 2010;4:708-15.
11. Rumbaugh KP, Griswold JA, Hamood AN. Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: Variations in virulence factors and virulence genes. J Hosp Infect 1999;43:211-8.
12. El-Feky MA, El-Rehewy MS, Hassan MA, AboLella HA, Abd El-Baky RM, Gad GF. Effect of ciprofloxacin and N-acetyl cystein on bacterial adherence and biofilm formation on uretral stent. Pol J Microbiol 2009;58:261-7.
13. Spoering, AL, Lewis K. Biofilms and Planktonic Cells of Pseudomonas aeruginosa have similar resistance to killing by Antimicrobials. J Bacteriol 2001;183:6746-51.
14. Aiassa V, Barnes AI, Albesa I. Resistance to ciprofloxacin by enhancement of antioxidant defenses in biofilm and planktonic Proteus mirabilis. Biochem Biophys Res Commun 2010;393:84-8.